Variant mannose-binding lectin 2 genotype is a risk factor for reactive systemic amyloidosis in rheumatoid arthritis

Journal of Internal Medicine
C P J MauryM Hurme

Abstract

The aim of this study was to investigate whether polymorphism of the mannose-binding lectin 2 (MBL2) gene is related to the occurrence of systemic AA amyloidosis in patients with rheumatoid arthritis (RA). MBL2 structural gene polymorphisms at codon 52 (CGT-->TGT, Arg-->Cys; D), codon 54 (GGC-->GAC, Gly-->Asp; B) and codon 57 (GGA-->GAA, Gly--> Glu; C), and MBL2 promoter region polymorphism at position -221 (G-->C) were examined in 57 patients with RA complicated by biopsy-proven reactive amyloidosis and 51 control RA patients without amyloid. A strong association was found between the presence of a structural MBL2 gene variant O (B, D or C) and the occurrence of amyloidosis in RA patients: 29 of 57 (50.9%) of the RA patients with amyloid had a variant allele compared with 12 of 51 (23.5%) of the RA patients without amyloid (OR 3.37, 95% CI 1.47-7.72; P = 0.004). We conclude that variant MBL2 structural genotype constitutes a significant risk factor for reactive amyloidosis in RA and that the increased risk is probably related to MBL-mediated impairment of mononuclear phagocyte function.

References

Nov 27, 2015·Molecular Immunology·Stefanie Epp BoschmannIara José de Messias-Reason
Oct 1, 2009·Arthritis and Rheumatism·Laura ObiciGiampaolo Merlini
Jan 14, 2012·Aging Cell·Rossella TomaiuoloLuca Deiana
Aug 13, 2011·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Barbara Kluve-BeckermanAdam Mullick
Mar 7, 2013·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Wataru IshiiBarbara Kluve-Beckerman
Aug 2, 2008·Expert Opinion on Pharmacotherapy·T PetterssonC P J Maury
Oct 18, 2011·The Journal of Rheumatology·Fernanda Leticia MartinyJosé Artur Bogo Chies

Citations

May 1, 1985·The Journal of Experimental Medicine·A Fuks, D Zucker-Franklin
May 6, 1998·British Journal of Rheumatology·S J StanworthN Snowden
Apr 12, 2001·Clinical and Experimental Immunology·K MigitaK Eguchi
Nov 6, 2003·Journal of Electron Microscopy·Mie KuroiwaNaotaka Izumiyama
Feb 12, 2004·Scandinavian Journal of Immunology·D Ham, S C Skoryna
Mar 24, 2004·Seminars in Cell & Developmental Biology·Christopher M Dobson
Aug 6, 2005·Autoimmunity Reviews·Akito TsutsumiTakayuki Sumida
Aug 18, 2005·Internal Medicine Journal·D L WorthleyC G Mullighan
Sep 24, 2005·Clinical and Experimental Immunology·J AittoniemiJ Karjalainen
Jan 6, 2006·Genes and Immunity·P GarredH O Madsen
Jan 18, 2006·Annual Review of Medicine·Mark B Pepys
May 9, 2006·Cell·Bernd BukauArthur Horwich

Related Concepts

Reactive Systemic Amyloidosis
APP protein, human
Mannose Binding Lectin
Amyloidosis
MBL2 protein, human
Rheumatoid Arthritis
Amyloid Deposition
Codon Genus
Codon (Nucleotide Sequence)
Amyloid

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.